DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
European Medicines Agency (EMA).
CHMP Assessment Report for Onglyza. International Nonproprietary Name: saxagliptin. Procedure No. EMEA/H/C/001039.
2009 [cited: 2013 Jul 04]. Available from:
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001039/WC500044319.pdf
Access:
We do not assume any responsibility for the contents of the web pages of other providers.